Home › Funds › FULTON BREAKEFIELD BROENNIMAN LLC › UNH
FULTON BREAKEFIELD BROENNIMAN LLC position in UNH
UNITEDHEALTH GROUP INC · Health Care
FULTON BREAKEFIELD BROENNIMAN LLC reported holding 28,249 shares of UNH (UNITEDHEALTH GROUP INC) in its Q3 2026 13F filing — a position valued at US$10.4M, representing 0.61% of its reported portfolio and ranking #41 among its reported holdings. FULTON BREAKEFIELD BROENNIMAN LLC has disclosed UNH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How FULTON BREAKEFIELD BROENNIMAN LLC's UNH position evolved
FULTON BREAKEFIELD BROENNIMAN LLC first disclosed a stake in UNH in Q3 2023 at 64,170 shares (US$32.4M). The position peaked in Q3 2024 at 60,217 shares, worth US$35.2M. Across 13 filings, FULTON BREAKEFIELD BROENNIMAN LLC increased the stake 0 time(s), trimmed it 11 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 28,249 shares valued at US$10.4M — a reduction of -13,159 shares quarter over quarter.. Notable position changes include a 32% trim in Q3 2026 (shares rose 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 64.17K | $32.35M | New |
| Q4 2023 | 64.28K | $33.84M | Hold |
| Q1 2024 | 63.64K | $31.48M | Reduce |
| Q2 2024 | 62.39K | $31.77M | Reduce |
| Q3 2024 | 60.22K | $35.21M | Reduce |
| Q4 2024 | 59.45K | $30.07M | Reduce |
| Q1 2025 | 57.63K | $30.18M | Reduce |
| Q2 2025 | 54.84K | $17.11M | Reduce |
| Q3 2025 | 49.13K | $16.96M | Reduce |
| Q4 2025 | 45.04K | $14.87M | Reduce |
| Q1 2026 | 42.66K | $11.54M | Reduce |
| Q2 2026 | 41.41K | $17.21M | Reduce |
| Q3 2026 | 28.25K | $10.37M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UNH and 13F data
UNH (UNITEDHEALTH GROUP INC) is a Health Care company. 29 other funds we track also report a position in UNH — the largest reported positions include BlackRock Inc (US$31.95B), Vanguard Group (US$30.24B), VANGUARD CAPITAL MANAGEMENT LLC (US$21.57B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UNH
- BlackRock Inc 76.86M sh · $31.95B · Q2 2026
- Vanguard Group 91.60M sh · $30.24B · Q4 2025
- VANGUARD CAPITAL MANAGEMENT LLC 58.76M sh · $21.57B · Q3 2026
- STATE STREET CORP 45.70M sh · $16.78B · Q3 2026
- Capital World Investors 29.89M sh · $12.42B · Q2 2026
- Fidelity Management & Research (FMR) 31.06M sh · $11.40B · Q3 2026
- Capital World Investors 28.48M sh · $10.46B · Q3 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 23.15M sh · $9.62B · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 24.58M sh · $9.02B · Q3 2026
- GEODE CAPITAL MANAGEMENT, LLC 21.75M sh · $9.01B · Q2 2026
- Charles Schwab Investment Management 19.83M sh · $8.24B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 19.83M sh · $8.24B · Q2 2026
More on FULTON BREAKEFIELD BROENNIMAN LLC
FAQ
How long has FULTON BREAKEFIELD BROENNIMAN LLC held UNH?
FULTON BREAKEFIELD BROENNIMAN LLC has disclosed UNH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is FULTON BREAKEFIELD BROENNIMAN LLC's current position in UNH?
As of Q3 2026, FULTON BREAKEFIELD BROENNIMAN LLC holds 28.25K shares of UNH (UNITEDHEALTH GROUP INC), valued at $10.37M, representing 0.61% of its reported portfolio and ranking #41.
Has FULTON BREAKEFIELD BROENNIMAN LLC been buying or selling UNH?
In the latest 13F filing (Q3 2026), FULTON BREAKEFIELD BROENNIMAN LLC reduced its position in UNH. The position peaked in Q3 2024 at 60.22K shares.
Which other funds hold UNH?
Other major institutional holders of UNH include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.